Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses

NCT01505894 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 409306
DRUG: Placebo

Sponsor

Boehringer Ingelheim